T-cell densities and their ratios were tested as prognostic variables for disease-free survival (DFS) and time to recurrence (TTR).<h4>Results</h4>We found greater densities of CD4+ cells in OM and PT of LM of synchronous and metachronous patients compared to pCRC. This evidence concerns the gene CD4 and ocular melanoma.